Dataemia

Atlas Venture, a prominent venture capital firm in the biotech industry, has raised $450 million for its 14th fund. The fund will focus on seed and series A rounds for biotech companies, with Atlas often playing a role in creating these companies. Unlike other firms, Atlas does not usually accept pitches from outside entrepreneurs, but…

, 2025-04-20 17:19:00 A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to obesity, diabetes, and cardiovascular disease. Fibrosis, driven by abnormal extracellular matrix (ECM) accumulation, disrupts normal adipose tissue function and contributes to broader organ dysfunction….

, 2025-04-22 03:26:00 Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure or medication that can reverse or stop the progression of PPA. The standard practice in the clinical setting is speech-language therapy to help people with PPA maintain their ability to communicate.  University of…

A review published in Frontiers in Immunology found a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD). The analysis included 19 studies with 1,549,181 participants, showing a significant association between RA and increased COPD risk. Likewise, individuals with COPD had an increased risk for RA, particularly among women and in cohort…

Glucagon-like peptide 1 (GLP-1) medications are effective weight loss tools for obese individuals, but many patients struggle with side effects such as nausea, vomiting, constipation, and dehydration. Adjusting the dosage gradually and following a diet rich in fiber and smaller, easily digested meals can help manage these side effects. Hydration and avoiding heavy, fatty foods…

Emma Bascom , 2025-04-29 19:20:00 April 29, 2025 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process…

, 2025-05-20 22:30:00 Credit: Unsplash/CC0 Public Domain Trauma centers nationwide will begin to test a new approach for assessing traumatic brain injury (TBI) that is expected to lead to more accurate diagnoses and more appropriate treatment and follow-up for patients. The new framework, which was developed by a coalition of experts and patients from 14…

Three Democratic senators are asking for an investigation into the costs of Georgia’s Medicaid work requirement program, which has cost tens of millions in federal and state dollars for administration and consulting fees. The senators are concerned about the true costs of the Republican health care agenda and want an independent watchdog to assess the…

Ed Silverman , 2025-04-29 20:00:00 Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. Gilead Sciences agreed to pay $202 million to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines, the latest example of a controversial…

Joanna Mulvaney PhD , 2025-05-01 14:24:00 A study published this morning in the Lancet Child and Adolescent Health, announces that the monoclonal antibody, nirsevimab, prevents severe respiratory syncytial virus infections in infants. In a huge review of the published evidence, epidemiologists from University of Toronto and York University, Toronto, tracked how effective nirsevimab was when…

Private prison contractor GEO Group filed a lawsuit against California officials over a state law allowing public health inspections at immigration detention facilities. The company claims the law is unconstitutional and interferes with federal immigration enforcement. The lawsuit names Gov. Gavin Newsom, Attorney General Rob Bonta, and a health officer as defendants. GEO’s stock rose…

Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try again later. If you continue to have…

, 2025-04-25 16:29:00 In 2019, the screening up-to-date status was 75.9% in Hispanic, 77.2% in Black, 81.8% in white, and 83.0% in Asian members (A). Concordant with increased screening prevalence, CRC incidence rates in these four groups increased from 109.1 to 126.4 cases per 100,000 in 2002 (B), peaked during 2008-2010, consistent with increased early…

Elaine Chen and Adam Feuerstein , 2025-05-16 19:19:00 The Food and Drug Administration approved on Friday the first blood test for diagnosing Alzheimer’s disease, opening up a quicker way for patients to get detected for the neurological condition and receive treatment. The test, developed by Japan-based Fujirebio Diagnostics, uses a blood sample to detect the…

, 2025-04-26 17:43:00 Credit: CC0 Public Domain As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS)—a condition that affects infants whose mothers used opioids during pregnancy—has risen 5-fold over the past 20 years. According to the Centers for Disease Control (CDC), there are 20,000 infants a year in…

Nick Hopkinson, Sanjay Agrawal, Ranee Thakar, Charmaine Griffiths, Ian Walker, and J Robert Branston are among the 200 organizations and individuals urging the UK government to invest in creating a smoke-free UK to improve public health and the economy. They argue that ending the tobacco epidemic is crucial, given the £93bn annual cost of smoking…

Portugal’s health system focuses on primary care and public health, leading to longer life expectancy and lower healthcare costs compared to the U.S. The country’s success is attributed to a national health care system that provides free or low-cost healthcare to all residents. Portugal implements innovative programs like “social prescribing” and has effectively addressed drug…

, 2025-04-25 16:58:00 by I. Edwards Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax’s stock up more than 21% in early trading. It also helped ease fears that the decision had been delayed by the Trump Administration, The Associated…

The study aimed to investigate the impact of tenofovir amibufenamide (TMF) on blood lipid profiles in chronic hepatitis B (CHB) patients over 48 weeks. 91 CHB patients were divided into two groups based on baseline lipid levels. Results showed that after 48 weeks of TMF treatment, there was no significant change in lipid indices compared…

GSK’s drug Blenrep, previously pulled from the market, has shown promising results in a Phase 3 study for treating multiple myeloma earlier in the treatment process. The drug has demonstrated longer progression-free survival and overall survival rates compared to standard regimens. Blenrep targets BCMA, a protein on multiple myeloma cells, and has the potential to…

, 2025-04-25 12:00:00 TOPLINE: Patients with inflammatory bowel disease (IBD) showed significantly lower muscle strength than matched healthy individuals, with women showing particularly worse nutritional status in terms of fat-free body mass and muscle mass and a higher incidence of sarcopenia. METHODOLOGY: Researchers conducted a case-control study comparing the nutritional status of 80 adults with…

, 2025-05-07 07:53:00 SAN DIEGO — Patients with obesity and type 2 diabetes treated with glucagon-like peptide 1 (GLP-1) receptor agonists had significantly reduced rates for colorectal cancer (CRC) risk and associated mortality compared with those undergoing bariatric surgery, new research showed. CRC risk was also lower for patients taking GLP-1s than the general population….

Robert Herpen, MA , 2025-04-18 13:30:00 April 18, 2025 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to…

Researchers from the Karolinska Institutet in Sweden have found that long-term use of common cardiovascular drugs may offer protection against dementia. The study, which involved 88,000 individuals over 70 years old, found that using antihypertensive drugs, cholesterol-lowering drugs, diuretics, and blood-thinning drugs for more than five years was associated with a lower risk of dementia….